44 related articles for article (PubMed ID: 36722026)
1. Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity.
Salvagno GL; Pighi L; Henry BM; Valentini M; Tonin B; Bragantini D; Gianfilippi G; De Nitto S; Plebani M; Lippi G
Clin Chem Lab Med; 2023 Jun; 61(7):1343-1348. PubMed ID: 36722026
[TBL] [Abstract][Full Text] [Related]
2. PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patients.
Castellano G; Netti GS; Cantaluppi V; Losappio V; Spadaccino F; Ranieri E; Marengo M; Borzumati M; Alfieri C; Stallone G
Sci Rep; 2024 May; 14(1):12217. PubMed ID: 38806543
[TBL] [Abstract][Full Text] [Related]
3. Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic.
Costanzo GAML; Deiana CM; Sanna G; Perra A; Campagna M; Ledda AG; Coghe F; Palmas V; Cappai R; Manzin A; Chessa L; Del Giacco S; Firinu D
J Clin Immunol; 2023 Dec; 44(1):12. PubMed ID: 38129351
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
Ramos A; Martins S; Marinho AS; Norton P; Cardoso MJ; Guimarães JT
PLoS One; 2024; 19(5):e0303244. PubMed ID: 38728294
[TBL] [Abstract][Full Text] [Related]
5. Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.
Salvagno GL; Henry BM; di Piazza G; Pighi L; De Nitto S; Bragantini D; Gianfilippi GL; Lippi G
Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34064509
[TBL] [Abstract][Full Text] [Related]
6. Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination.
Montmaneix-Engels F; Dimeglio C; Staes L; Da Silva I; Porcheron M; Jougla I; Hérin F; Izopet J
Heliyon; 2024 Apr; 10(7):e29116. PubMed ID: 38601689
[TBL] [Abstract][Full Text] [Related]
7. Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.
Favresse J; Gillot C; Closset M; Cabo J; Wauthier L; David C; Elsen M; Dogné JM; Douxfils J
J Med Virol; 2024 Jan; 96(1):e29365. PubMed ID: 38185981
[TBL] [Abstract][Full Text] [Related]
8. Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study.
Salvagno GL; Pighi L; Henry BM; De Nitto S; Plebani M; Lippi G
Clin Chem Lab Med; 2023 Aug; 61(9):e172-e174. PubMed ID: 36913440
[No Abstract] [Full Text] [Related]
9. High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: A single-center cross-sectional study.
von der Schulenburg P; Herting A; Harberts A; Lütgehetmann M; Jahnke-Triankowski J; Pischke S; Piecha F; Drolz A; Jörg V; Hübener P; Wehmeyer M; Addo MM; Fischer L; Lohse AW; Schulze Zur Wiesch J; Sterneck M
United European Gastroenterol J; 2024 Apr; 12(3):339-351. PubMed ID: 38279837
[TBL] [Abstract][Full Text] [Related]
10. Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers.
Salvagno GL; Henry BM; Pighi L; de NS; Lippi G
J Med Biochem; 2022 Apr; 41(2):199-203. PubMed ID: 35510202
[TBL] [Abstract][Full Text] [Related]
11. Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents.
Rothoeft T; Maier C; Talarico A; Hoffmann A; Schlegtendal A; Lange B; Petersmann A; Denz R; Timmesfeld N; Toepfner N; Vidal-Blanco E; Pfaender S; Lücke T; Brinkmann F
Infection; 2024 Mar; ():. PubMed ID: 38499828
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study.
Costanzo GAML; Sanna G; Pes F; Deiana CM; Ledda AG; Perra A; Palmas V; Manca V; Miglianti M; Coghe F; Manzin A; Del Giacco S; Chessa L; Firinu D
Pathogens; 2024 Jun; 13(6):. PubMed ID: 38921803
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ Release Assay in the Assessment of Cellular Immunity-A Single-Centre Experience with mRNA SARS-CoV-2 Vaccine in Patients with Juvenile Idiopathic Arthritis.
Kapten K; Orczyk K; Maeser A; Smolewska E
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731052
[No Abstract] [Full Text] [Related]
14. Integrating SARS-CoV-2-specific interferon-γ release assay testing in the evaluation of patients hospitalized with COVID-19.
Masiá M; de la Rica A; Fernández-González M; García JA; Padilla S; García-Abellán J; Botella Á; Mascarell P; Gutiérrez F
Microbiol Spectr; 2023 Dec; 11(6):e0241923. PubMed ID: 37855635
[TBL] [Abstract][Full Text] [Related]
15. High baseline expression of IL-6 and IL-10 decreased CCR7 B cells in individuals with previous SARS-CoV-2 infection during BNT162b2 vaccination.
Ponciano-Gómez A; Valle-Solis MI; Campos-Aguilar M; Jijón-Lorenzo R; Herrera-Cogco EC; Ramos-Alor R; Bazán-Mendez CI; Cervantes GAP; Ávila-García R; Aguilar AG; Texale MGS; Tapia-Sánchez WD; Duarte-Martínez CL; Olivas-Quintero S; Sigrist-Flores SC; Gallardo-Ortíz IA; Villalobos-Molina R; Méndez-Cruz AR; Jimenez-Flores R; Santos-Argumedo L; Luna-Arias JP; Romero-Ramírez H; Rosales-García VH; Avendaño-Borromeo B
Front Immunol; 2022; 13():946770. PubMed ID: 36052060
[TBL] [Abstract][Full Text] [Related]
16. Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.
Blazquez-Navarro A; Safi L; Meister TL; Thieme CJ; Kaliszczyk S; Paniskaki K; Stockhausen M; Hörstrup J; Cinkilic O; Flitsch-Kiefner L; Marheinecke C; Steinmann E; Seibert FS; Stervbo U; Westhoff TH; Pfaender S; Roch T; Babel N
Kidney Int; 2021 Sep; 100(3):698-700. PubMed ID: 34273381
[No Abstract] [Full Text] [Related]
17. Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
Harries M; Jaeger VK; Rodiah I; Hassenstein MJ; Ortmann J; Dreier M; von Holt I; Brinkmann M; Dulovic A; Gornyk D; Hovardovska O; Kuczewski C; Kurosinski MA; Schlotz M; Schneiderhan-Marra N; Strengert M; Krause G; Sester M; Klein F; Petersmann A; Karch A; Lange B
Int J Infect Dis; 2024 Feb; 139():50-58. PubMed ID: 38008353
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Roche Elecsys® IGRA SARS-CoV-2 test for the detection and quantification of virus-reactive T cells in COVID-19-vaccinated immunosuppressed patients and healthy subjects.
Carretero D; Giménez E; Albert E; Colomer E; Montomoli M; Hernani R; Piñana JL; Górriz JL; Solano C; Navarro D
Eur J Clin Microbiol Infect Dis; 2024 May; ():. PubMed ID: 38777919
[TBL] [Abstract][Full Text] [Related]
19. Combining SARS-CoV-2 interferon-gamma release assay with humoral response assessment to define immune memory profiles.
Mouton W; Oriol G; Compagnon C; Saade C; Saker K; Franc P; Mokdad B; Fleurie A; Lacoux X; Daniel S; Berthier F; Barnel C; Pozzetto B; Fassier JB; Dubois V; Djebali S; Dubois M; Walzer T; Marvel J; Brengel-Pesce K; Trouillet-Assant S;
Eur J Immunol; 2024 Apr; ():e2451035. PubMed ID: 38627984
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination.
Stankov MV; Hoffmann M; Gutierrez Jauregui R; Cossmann A; Morillas Ramos G; Graalmann T; Winter EJ; Friedrichsen M; Ravens I; Ilievska T; Ristenpart J; Schimrock A; Willenzon S; Ahrenstorf G; Witte T; Förster R; Kempf A; Pöhlmann S; Hammerschmidt SI; Dopfer-Jablonka A; Behrens GMN
Lancet Infect Dis; 2024 Jan; 24(1):e1-e3. PubMed ID: 37995739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
